SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002337
Filing Date
2023-11-13
Accepted
2023-11-13 06:11:17
Documents
71
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zura-20230930x10q.htm   iXBRL 10-Q 1716501
2 EX-31.1 zura-20230930xex31d1.htm EX-31.1 11140
3 EX-31.2 zura-20230930xex31d2.htm EX-31.2 11152
4 EX-32.1 zura-20230930xex32d1.htm EX-32.1 6008
5 EX-32.2 zura-20230930xex32d2.htm EX-32.2 5734
  Complete submission text file 0001410578-23-002337.txt   7612942

Data Files

Seq Description Document Type Size
6 EX-101.SCH zura-20230930.xsd EX-101.SCH 73771
7 EX-101.CAL zura-20230930_cal.xml EX-101.CAL 36288
8 EX-101.DEF zura-20230930_def.xml EX-101.DEF 306709
9 EX-101.LAB zura-20230930_lab.xml EX-101.LAB 566907
10 EX-101.PRE zura-20230930_pre.xml EX-101.PRE 470641
65 EXTRACTED XBRL INSTANCE DOCUMENT zura-20230930x10q_htm.xml XML 1067414
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40598 | Film No.: 231394736
SIC: 2836 Biological Products, (No Diagnostic Substances)